As a major survival pathway in cancer cells, the constitutively activated PI3K–AKT signaling pathway mediated through molecular aberrations drives the process of tumor promotion and resistance to chemotherapy (Liu et al., 2009; Janku et al., 2012). This evidence concerns the gene AKT1 and neoplasm.